Use of oxygen and opioids in the palliation of dyspnoea in hypoxic and non-hypoxic palliative care patients: a prospective study
- 1.3k Downloads
Dyspnoea is a complex experience of the body and the mind. Whereas the effects of opioids on dyspnoea in advanced disease have been the focus of studies for management of dyspnoea in palliative medicine, the role of oxygen is still unclear. The effects of symptomatic oxygen and opioid treatment on ventilation and palliation of dyspnoea in hypoxic (H) and non-hypoxic (NH) palliative care patients were assessed and compared.
In a prospective, non-randomised study, 46 patients with mild to severe dyspnoea were included. Transcutaneous measurement (earlobe sensor) of carbon dioxide partial pressure (tcpaCO2), pulse oximetry oxygen saturation (SaO2) and pulse frequency (PF) were monitored with SenTec digital monitor. Compared was: baseline data of the continuously documented respiratory parameters for about 15 min in patients breathing room air at admission, 60 min during nasal O2 insufflation, and 30, 90 and 120 min after the first opioid application and without O2 insufflation.
Whereas opioid application resulted in a significant decrease in the intensity of dyspnoea and respiratory rate, during the nasal O2 insufflation (4 l/min), there was no significant decrease in the intensity of dyspnoea neither in H (P = 0.564) nor in NH (P = 0.096) patients. There was no evidence of a significant correlation between the intensity of dyspnoea and oxygen saturation. The Spearman rank correlation in NH patients was −0.080 (P = 0.686) and in H patients P = 0.296 (P = 0.233). No significant differences between the groups of hypoxic and non-hypoxic patients with regard to tcpaCO2 increase (P = 0.075 NH; P = 0.346 H) or SaO2 decrease after opioid application (P = 0.077) were found.
In this study, opioids worked significantly better than oxygen in reducing the intensity of dyspnoea even in hypoxic patients. There was no correlation between intensity of dyspnoea and oxygen saturation in H and NH patients. Oxygen should be seen as a pharmacological agent and not be given based on intuitive assumption of benefit.
KeywordsHypoxaemia Hypercapnia Respiratory depression Opioids Oxygen saturation Transcutaneous capnometry Dyspnoea
The authors would like to thank Birgit Jaspers for careful review of this manuscript and English editing.
This study is sponsored by Deutsche Krebshilfe e.V. (German Cancer Aid). The sponsor had no impact on the investigator-initiated work of the authors.
- 17.Cohen RM, Carson RE, Channing M et al (1988) F-18-Cyclofoxy PET imaging in man. J Nucl Med 29:796Google Scholar
- 20.Eberhard P, Gisiger PA, Gardaz JP et al (2002) Combining transcutaneous blood gas measurement and pulse oximetry. Anesth Analg 94(Suppl):76–80Google Scholar
- 27.Hanly PJ (1998) Transcutaneous monitoring of carbon dioxide tension. In: Tobin MJ (ed) Principles and practice of intensive care monitoring. McGraw-Hill, New York, pp 401–414Google Scholar
- 34.Nunn JF (1975) Applied respiratory physiology with special reference to anaesthesia. Butterworths, LondonGoogle Scholar
- 36.Pauwels RA, Buist AS, Calverley PMA et al (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care 46:798–825PubMedGoogle Scholar
- 37.Pfeiffer C, Poline JB, Thivard L et al (2001) Neural substrates for the perception of acutely induced dyspnea. Am J Respir Crit Care Med 163:951–957Google Scholar
- 41.Spathis A, Wade R, Booth S (2006) Oxygen in the palliation of breathlessness. In: Booth S, Dudgeon D (eds) Dyspnoea in advanced disease. Oxford University Press, Oxford, pp 205–236Google Scholar